Virus-like particles mimic the external structure of viruses go to this link.

Virus-like particles mimic the external structure of viruses, however, not the live genetic material that causes viral replication and infection VLPs can be developed rapidly to individual strains correspond and produces efficient use of portable cell culture. Technology Novavax VLP – based vaccine candidates are produced more quickly than egg-based vaccines by using proprietary, portable, recombinant cell culture technology. go to this link

The Company conference call to discuss this clinical study at 9:00 am am on clock Tuesday, October 2009. Calling will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of the company ‘s senior management team will follow. A question – and – answer session. Forward-Looking Statements into the clinical phase biotechnology company creating novel vaccines to the world a wide range of infectious diseases, including H1N1, to address using advanced proprietary virus-like – particle technology. The company produces potent VLP-based recombinant vaccines using new and efficient manufacturing approaches. Novavax is to do with its VLP technology to country-specific vaccine solutions required. It has. Recently a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop vaccines vaccines, biological therapeutics and diagnostics in India.

In the year 2006 expanded that Medicare Part D. Prescription drug program benefits millions of beneficiaries. Part D prescription medicine used cover include 2006 up to $ 2,250 in total drug costs – what the patient and Map each had the paid for the point to the the beneficiary donut hole, where Medicare not pay anything listed on the drug costs, $ 3,600 reach $ 3,600 a total of annually out-of-pocket drug costs. – The[ donut hole] is encourage patients to take advantage drugs more sensibly and save money Compare, deposition said. But It may also cause financial obstacles to usage necessary medicines. .

go to this link

Bruce Stuart, CEO of the Peter Lamy Center on Drug Therapy and Aging Baltimore has an explanation: introduced in 2006, Wal-Mart 30-day shipping of generic drugs for $ 4. ‘The co-payment for generics being $ 8.50 to $ 10 a group group of generic – one gap. This is only possible too great a difference in the cost. Generic medicines The Medicare advantage is not worth it for many people are,’he said. In addition, Stuart said to study underestimated underestimated the actually impact of gap on beneficiaries.